New SF health chief helped market opioid for McKinsey

Mayor Lurie's appointment of Daniel Tsai as San Francisco's Public Health chief has sparked controversy due to Tsai's past involvement at McKinsey in marketing opioids, specifically tramadol, during the onset of America's opioid crisis. While Tsai brings extensive experience in Medicaid programs and healthcare leadership, his appointment has raised concerns among local health service providers about transparency and expertise in evidence-based interventions.